FACTS

• Repetitive Motion Strain: Performing the same movements continuously without breaks increases stress on muscles and tendons, leading to overuse injuries.
• Prolonged Static Postures: Holding the same position for extended periods reduces blood flow and accelerates muscle fatigue and discomfort.
• Cumulative Fatigue: Fatigue builds gradually throughout a shift when recovery time is not provided, increasing the likelihood of errors and injuries.
• Reduced Reaction Time: Physical and mental fatigue slows response time, raising the risk of incidents in both low- and high-risk tasks.
• Muscle Imbalance and Tension: Continuous work without recovery leads to tight, overworked muscle groups and increased strain on joints.
• Decreased Concentration: Lack of breaks reduces focus and awareness, making it easier to miss hazards or make unsafe decisions.
• Delayed Injury Onset: Overuse injuries often develop slowly, meaning workers may not recognize the risk until significant damage has occurred.

STATS

• In the United States, musculoskeletal disorders account for nearly 30% of all workplace injuries requiring days away from work, many linked to repetitive tasks and lack of recovery time (U.S. Bureau of Labor Statistics, 2022–2023).
• U.S. data shows that overexertion and repetitive motion are among the leading causes of workplace injuries, resulting in thousands of cases each year (BLS, 2021–2023).
• In Canada, musculoskeletal injuries are the most common type of lost-time workplace injury, frequently associated with repetitive work and insufficient rest (Association of Workers’ Compensation Boards of Canada, recent years).
• U.S. occupational data indicates that fatigue contributes to a significant portion of workplace incidents, affecting attention, coordination, and decision-making (National Safety Council, 2021–2023).
• In Canada, workplace data shows that repetitive strain injuries and overexertion account for a large share of compensation claims annually, particularly in manual and office-based roles (AWCBC, 2021–2023).